These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 21668447)

  • 1. Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum.
    Howard CD; Keefe KA; Garris PA; Daberkow DP
    J Neurochem; 2011 Aug; 118(4):668-76. PubMed ID: 21668447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methamphetamine-induced neurotoxicity disrupts pharmacologically evoked dopamine transients in the dorsomedial and dorsolateral striatum.
    Robinson JD; Howard CD; Pastuzyn ED; Byers DL; Keefe KA; Garris PA
    Neurotox Res; 2014 Aug; 26(2):152-67. PubMed ID: 24562969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methamphetamine-induced neurotoxicity disrupts naturally occurring phasic dopamine signaling.
    Howard CD; Daberkow DP; Ramsson ES; Keefe KA; Garris PA
    Eur J Neurosci; 2013 Jul; 38(1):2078-88. PubMed ID: 23574406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phasic-like stimulation of the medial forebrain bundle augments striatal gene expression despite methamphetamine-induced partial dopamine denervation.
    Howard CD; Pastuzyn ED; Barker-Haliski ML; Garris PA; Keefe KA
    J Neurochem; 2013 May; 125(4):555-65. PubMed ID: 23480199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine.
    Cass WA
    J Pharmacol Exp Ther; 1997 Jan; 280(1):105-13. PubMed ID: 8996187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term changes in basal ganglia function after a neurotoxic regimen of methamphetamine.
    Chapman DE; Hanson GR; Kesner RP; Keefe KA
    J Pharmacol Exp Ther; 2001 Feb; 296(2):520-7. PubMed ID: 11160639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine.
    Itzhak Y; Martin JL; Ali SF
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1177-83. PubMed ID: 12452543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methamphetamine-induced neurotoxicity: roles for glutamate and dopamine efflux.
    Stephans SE; Yamamoto BK
    Synapse; 1994 Jul; 17(3):203-9. PubMed ID: 7974204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glial reactivity in resistance to methamphetamine-induced neurotoxicity.
    Friend DM; Keefe KA
    J Neurochem; 2013 May; 125(4):566-74. PubMed ID: 23414433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors.
    Bhimani RV; Vik M; Wakabayashi KT; Szalkowski C; Bass CE; Park J
    J Neurochem; 2021 Aug; 158(4):865-879. PubMed ID: 34265079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel electrochemical approach for prolonged measurement of absolute levels of extracellular dopamine in brain slices.
    Burrell MH; Atcherley CW; Heien ML; Lipski J
    ACS Chem Neurosci; 2015 Nov; 6(11):1802-12. PubMed ID: 26322962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships among gender, age, time, and temperature in methamphetamine-induced striatal dopaminergic neurotoxicity.
    Dluzen DE; McDermott JL; Darvesh AS
    Neuroscience; 2010 Jun; 167(4):985-93. PubMed ID: 20211701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
    Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of parkin in the rat nigrostriatal dopamine system protects against methamphetamine neurotoxicity.
    Liu B; Traini R; Killinger B; Schneider B; Moszczynska A
    Exp Neurol; 2013 Sep; 247():359-72. PubMed ID: 23313192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methamphetamine exposure during the preweanling period causes prolonged changes in dorsal striatal protein kinase A activity, dopamine D2-like binding sites, and dopamine content.
    Crawford CA; Williams MT; Newman ER; McDougall SA; Vorhees CV
    Synapse; 2003 Jun; 48(3):131-7. PubMed ID: 12645038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A role for D1 dopamine receptors in striatal methamphetamine-induced neurotoxicity.
    Friend DM; Keefe KA
    Neurosci Lett; 2013 Oct; 555():243-7. PubMed ID: 23994061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age as a susceptibility factor in the striatal dopaminergic neurotoxicity observed in the mouse following substituted amphetamine exposure.
    Miller DB; O'Callaghan JP; Ali SF
    Ann N Y Acad Sci; 2000 Sep; 914():194-207. PubMed ID: 11085321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.
    Cadet JL; Brannock C; Krasnova IN; Ladenheim B; McCoy MT; Chou J; Lehrmann E; Wood WH; Becker KG; Wang Y
    PLoS One; 2010 Dec; 5(12):e15643. PubMed ID: 21179447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery of presynaptic dopaminergic functioning in rats treated with neurotoxic doses of methamphetamine.
    Cass WA; Manning MW
    J Neurosci; 1999 Sep; 19(17):7653-60. PubMed ID: 10460271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
    Killinger BA; Moszczynska A
    J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.